HIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Hospital Universitario Rey Juan Carlos, Móstoles, Spain.
Virulence. 2022 Dec;13(1):1713-1719. doi: 10.1080/21505594.2022.2129353.
Accumulation of mutations in epitopes of cytolytic--lymphocytes immune response (CTL) in HIV-reservoir seems to be one of the reasons for shock-and-kill strategy failure. Ten non-controller patients on successful cART (TX) and seven elite controllers (EC) were included. HIV-Gag gene from purified resting memory CD4+ -cells was sequenced by Next-Generation-Sequencing. HLA class-I alleles were typed to predict optimal HIV-Gag CTL epitopes. For each subject, the frequency of mutated epitopes in the HIV-Gag gene, the proportion of them considered as CTL-escape variants as well as their effect on antigen recognition by HLA were assessed. The proportion (%) of mutated HIV-Gag CTL epitopes in the reservoir was high and similar in EC and TX (86%[50-100] and 57%[48-82] respectively, p=0.315). Many of them were predicted to negatively impact antigen recognition. Moreover, the proportion of mutated epitopes considered to be CTL-escape variants was also similar in TX and EC (77%[49-92] vs. 50%[33-75] respectively, p=0.117). Thus, the most relevant finding of our study was the high and similar proportions of HIV-Gag CTL-escape mutations in the reservoir of both HIV-noncontroller patients with cART (TX) and patients with spontaneous HIV-control (EC). Our findings suggest that escape mutations of CTL-response may be another obstacle to eliminate the HIV reservoir and constitute a proof of concept that challenges HIV cure strategies focused on the reactivation of reservoirs. Due to the small sample size that could impact the robustness of the study, further studies with larger cohorts of elite controller patients are needed to confirm these results.
在 HIV 储存库中细胞毒性 - 淋巴细胞免疫反应 (CTL) 的表位突变的积累似乎是休克和杀伤策略失败的原因之一。纳入了 10 名接受成功 cART(TX)的非控制器患者和 7 名精英控制器(EC)。通过下一代测序对从纯化的静止记忆 CD4+ -细胞中提取的 HIV-Gag 基因进行测序。对 HLA 类 I 等位基因进行分型,以预测最佳的 HIV-Gag CTL 表位。对于每个受试者,评估 HIV-Gag 基因中突变表位的频率、被认为是 CTL 逃逸变体的比例以及它们对 HLA 识别抗原的影响。储存库中突变的 HIV-Gag CTL 表位的比例很高,在 EC 和 TX 中相似(分别为 86%[50-100]和 57%[48-82],p=0.315)。其中许多被预测会对抗原识别产生负面影响。此外,被认为是 CTL 逃逸变体的突变表位的比例在 TX 和 EC 中也相似(分别为 77%[49-92]与 50%[33-75],p=0.117)。因此,我们研究的最相关发现是,在接受 cART(TX)的 HIV 非控制器患者和具有自发 HIV 控制的患者(EC)的储存库中,HIV-Gag CTL 逃逸突变的比例很高且相似。我们的研究结果表明,CTL 反应的逃逸突变可能是消除 HIV 储存库的另一个障碍,并构成对专注于储存库再激活的 HIV 治愈策略的挑战的概念证明。由于可能影响研究稳健性的小样本量,需要进一步的研究以确认这些结果。